Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Wyeth presents various series of PAI-1 inhibitors

Feb. 11, 2003

Design and synthesis of potent and selective direct thrombin inhibitors

Feb. 10, 2003

ZymoGenetics initiates rFXIII phase I trials, signs exclusive licensing agreement

Feb. 7, 2003

MIT details the rational design of LMWHs with improved properties

Feb. 6, 2003

Baxter proposes Advate as brand name for rAHF-PFM

Feb. 6, 2003

Research term extended in 3DP thrombin collaboration

Feb. 6, 2003

Boehringer Ingelheim presents novel thrombin inhibitors

Feb. 6, 2003

Novel factor Xa inhibitors developed at BMS

Feb. 5, 2003

First treatment for acute ischemic stroke cleared for use in Europe

Jan. 29, 2003

Novel antagonists of platelet ADP (P2YAC) receptors discovered at Schering AG

Jan. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...